Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
呋莫替尼是一种第三代EGFR酪氨酸激酶抑制剂,它通过抑制癌细胞中的ABCB1和ABCG2来克服多药耐药性。
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241813972
Wu, Chung-Pu; Li, Yen-Ching; Murakami, Megumi; Hsiao, Sung-Han; Lee, Yun-Chieh; Huang, Yang-Hui; Chang, Yu-Tzu; Hung, Tai-Ho; Wu, Yu-Shan; Ambudkar, Suresh V
ABCG2
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
ABCB1
细胞生物学